"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Opens in a new tab or window Investigational transcranial magnetic stimulation that targeted a brain network involved in ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...

For adults aged 65 years and older with Alzheimer's disease, the emergency department visit rate was 36.1 visits per 1,000 ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...